The upregulation of transforming growth factor-β (TGF-β) signaling, a profibrotic cytokine, is considered a critical pathogenic and progression factor of DN by activating various signal transductions, expression of the extracellular matrix, and reactive oxygen species production [40,41]. This evidence concerns the gene TGFB1 and liver dysplastic nodule.